Monoaminergic selectivity of the antidepressive drugs and sleep: Neurophysiological implications of depression;Selectividad monoaminergica de los antidepresivos y sueno: Implicacion neurofisiologica de la depresion

Revista de Neurologia

Volumn 30, Issue 2, 2000, Pages 191-194

  Lorenzo, J L ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Antidepressive drugs; Depression; Neurotrunsmitters; Sleep

Indexed keywords

ANTIDEPRESSANT AGENT; NEUROTRANSMITTER; SEROTONIN UPTAKE INHIBITOR; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

ARTICLE; DEPRESSION; DRUG MECHANISM; HUMAN; NEUROPHYSIOLOGY; NEUROTRANSMISSION; SLEEP; SLEEP WAKING CYCLE; AROUSAL; DRUG EFFECT; METABOLISM; PATHOPHYSIOLOGY; REM SLEEP; REVIEW; SLEEP DISORDER; WAKEFULNESS;

AROUSAL; DEPRESSION; HUMANS; NEUROTRANSMITTER AGENTS; SEROTONIN UPTAKE INHIBITORS; SLEEP DISORDERS; SLEEP, REM; WAKEFULNESS;

EID: 0034672987     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3002.99637     Document Type: Article

References (15)

1. Gillin JC. Sleep studies in affective illness: diagnostic therapeutic and pathophysiological implications. Psychiatric Annals 1983; 13: 367-84.
2. Gillin JC, Borbély AA. Sleep: a neurological window on affective disorders. Trends Neurosci 1985; 8: 537-42.
3. Mendelson WB, Sack DA, James SP. Frequency analysis of the sleep EEC in depression. Psychiatry Res 1986; 21: 89-94.
4. Goetz RR, Puig-Antich J, Ryan N. Electroencephalographic sleep of adolescents with major depression and normal controls. Arch Gen Psychiatry 1987; 44: 61-8.
5. Feinberg I, Braum N, Koresko RL, Gottlieb F. Stage 4 in schizophrenia. Arch Gen Psychiatry 1969; 21: 262-6.
6. Gillin JC, Duncan WC, Pettigrew KD. Successful separation of depressed, normal, and insomniac subjects by sleep data. Arch Gen Psychiatry 1979; 36: 85-90.
7. Giles DE, Jarrett RB, Rofwarg HP, Rush AJ. Stability of polisomnographic parameters in unipolar depression: a cross-sectional report. Biol Psychiatry 1989; 25: 807-10.
8. Giles DE, Rofwarg HP, Rush AJ. A cross-sectional study of the effects of depression on REM latency. Biol Psychiatry 1990; 28: 697-704.
9. Wehr TA, Wirz-Justice A, Goodwin FK. Phase advance of the circadian sleep-wake cycle as an antidepressant. Science 1979; 206: 710-3.
10. Borbély AA. A two process model of sleep regulation. Hum Neurobiol 1982; 1: 195-204.
11. Me Carley RW. REM sleep and depression: common neurobiological control mechanisms. Am J Psychiatry 1982; 139: 565-70.
12. Sitaram N, Mendelson WB, Wyatt RJ. The time-dependent induction of REM sleep and arousal by physostigmine infusion during normal sleep. Brain Res 1977; 122: 552-7.
13. Velazquez-Moctezuma J, Shalauta M, Gillin JC, Shiromani PJ. Cholinergic antagonists and REM sleep generation. Brain Res 1991; 543: 175-9.
14. Gaillard JM. Biochemical pharmacology of paradoxical sleep. Br J Clin Pharmacol 1983; 16: S205-30.
15. Gaillard JM, Iorio G, Kafi S, Blois R. Paradoxical sleep without previous debut. The effect of minute doses of clonidine in man. Sleep 1983; 6: 60-6.